SCHEMBL34472876

SCHEMBL34472876

CCNc1cc(F)cc(Br)c1[N+](=O)[O-]

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCAR3 P49019 1/20 0.38
▸ LMNA P02545 2/20 0.37
▸ MAPT P10636 6/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ P2RY6 Q15077 1/20 0.33
▸ PTGER4 P35408 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ GAA P10253 2/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ PGK1 P00558 1/20 0.33
▸ GRIN2D O15399 1/20 0.32
▸ GRIN3B O60391 1/20 0.32
▸ GRIN1 Q05586 1/20 0.32
▸ GRIN2A Q12879 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27209599 0.84 HCAR3 (0.40) HCAR3LMNAMAPTSMN1; SMN2ALDH1A1
SCHEMBL18408922 0.82 MAPT (0.41) HCAR3LMNAMAPTSMN1; SMN2ALDH1A1
SCHEMBL29975369 0.77 P2RY6 (0.42) MAPTSMN1; SMN2ALDH1A1MAPK1L3MBTL1
SCHEMBL18322420 0.75 PTGER4 (0.45) HCAR3LMNAMAPTSMN1; SMN2ALDH1A1
SCHEMBL18340899 0.74 KAT2B (0.44) HCAR3LMNAMAPTALDH1A1MAPK1
SCHEMBL34472545 0.74 HCAR3 (0.40) HCAR3LMNAMAPTSMN1; SMN2ALDH1A1
SCHEMBL31426321 0.73 HCAR3 (0.39) HCAR3LMNAMAPTALDH1A1MAPK1
SCHEMBL9000095 0.72 ATM (0.44) MAPTSMN1; SMN2ALDH1A1MAPK1P2RY6
SCHEMBL30391374 0.72 ALDH1A1 (0.42) HCAR3LMNAMAPTSMN1; SMN2ALDH1A1
SCHEMBL31481963 0.71 MAPT (0.57) HCAR3LMNAMAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026087651-A1 CYCLOPROPANE-ARYL COMPOUNDS FOR THE TREATMENT OF CANCER SANOFI (FR) 2026-04-30 — — WO disclosed
Send feedback